It is noteworthy that the biochemical assessment of adipokines, especially adiponectin and resistin, can provide relevant information to the monitoring and prognosis of people undergoing treatment for obesity. This evidence concerns the gene RETN and obesity due to melanocortin 4 receptor deficiency.